01.03.2001 | Original Article
A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule
Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 3/2001
Einloggen, um Zugang zu erhalten